Discover
JAGX
Jaguar Health, Inc.
1.62
6 x 1.68
1 x 2.24
bid
ask
-
0.42
20.59%
4 @ 04:00 PM
1.60 -0.02 (1.17%)
| Ytd | -99.67% | |
| 1y | -99.84% |
1.60
day range
2.00
1.60
52 week range
1102.50
| Open | 2.00 | Prev Close | 2.04 | Low | 1.60 | High | 2.00 | Mkt Cap | 3.76M |
| Vol | 363.04K | Avg Vol | 2.15M | EPS | -4012.65 | P/E | N/A | Forward P/E | -0.37 |
| Beta | 0.88 | Short Ratio | 1.12 | Inst. Own | 1.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 6.69 | 200-d Avg | 122.10 | 1yr Est | 6.00 |
| Income Statement | |||
| Total Revenue | 1.23M | ||
| Revenues (USD) | 1.23M | ||
| Cost of Revenue | 1.03M | ||
| Gross Profit | 194.00K | ||
| Operating Expenses | 7.79M | ||
| Research and Development Expense | 3.34M | ||
| Selling, General and Administrative Expense | 4.46M | ||
| Operating Income | -7.60M | ||
| Interest Expense | 161.00K | ||
| Net Income | -12.68M | ||
| Net Income Common Stock | -12.70M | ||
| Net Income Common Stock (USD) | -12.70M | ||
| Consolidated Income | -12.80M | ||
| Net Income to Non-Controlling Interests | -120.00K | ||
| Earnings per Basic Share | -236.00 | ||
| Earnings per Basic Share (USD) | -236.00 | ||
| Earnings per Diluted Share | -236.00 | ||
| Earning Before Interest & Taxes (EBIT) | -12.52M | ||
| Earning Before Interest & Taxes (USD) | -12.52M | ||
| Preferred Dividends Income Statement Impact | 19.00K | ||
| Weighted Average Shares | 53.94K | ||
| Weighted Average Shares Diluted | 53.94K | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.59M | ||
| Cash and Equivalents (USD) | 6.59M | ||
| Trade and Non-Trade Receivables | 198.00K | ||
| Current Assets | 17.53M | ||
| Property, Plant & Equipment Net | 1.43M | ||
| Total Assets | 34.19M | ||
| Debt Current | 14.05M | ||
| Total Debt | 16.65M | ||
| Current Liabilities | 25.38M | ||
| Debt Non-Current | 2.60M | ||
| Total Liabilities | 29.27M | ||
| Accumulated Retained Earnings (Deficit) | -403.75M | ||
| Accumulated Other Comprehensive Income | -1.24M | ||
| Shareholders Equity | 6.62M | ||
| Shareholders Equity (USD) | 6.62M | ||
| Assets Non-Current | 16.66M | ||
| Total Debt (USD) | 16.65M | ||
| Deferred Revenue | 468.00K | ||
| Goodwill and Intangible Assets | 15.09M | ||
| Inventory | 7.32M | ||
| Liabilities Non-Current | 3.89M | ||
| Trade and Non-Trade Payables | 4.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 542.00K | ||
| Net Cash Flow from Financing | 1.86M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.47M | ||
| Issuance (Repayment) of Debt Securities | -118.00K | ||
| Net Cash Flow from Operations | -5.34M | ||
| Effect of Exchange Rate Changes on Cash | 2.00K | ||
| Share Based Compensation | 171.00K | ||